PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX (Ketamine) to the FDA - Seite 3

This news release does not constitute an offer to sell or the solicitation of an offer to buy, and shall not constitute an offer, solicitation or sale in any state, province, territory or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state, province, territory or jurisdiction.